Thromboxane and leukotrienes in clinical and experimental transplant rejection.
Foegh
M L
ML
Alijani
M R
MR
Helfrich
G B
GB
Khirabadi
B S
BS
Goldman
M H
MH
Lower
R R
RR
Ramwell
P W
PW
D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D003988:Dibenzothiepins / Q000627:therapeutic use; D006084:Graft Rejection / Q000187:drug effects*; D016027:Heart Transplantation; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents; D016030:Kidney Transplantation; D007975:Leukotriene B4 / Q000627:therapeutic use*; D008954:Models, Biological; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology; D013929:Thromboxane B2 / Q000652:urine; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D001095:Arachidonic Acids; D003988:Dibenzothiepins; D007166:Immunosuppressive Agents; D007975:Leukotriene B4; D016718:Arachidonic Acid; D013929:Thromboxane B2; C041107:L 640035; D010088:Oxidoreductases; D013930:Thromboxane-A Synthase